LIXTE Biotechnology Holdings, Inc. Investor Relations The following documents have been filed with the SEC: SEC FILING ALERT 10-Q: QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) HTML PDF If you have any questions, or would like to contact Investor Relations, please reply to this email. LIXTE Biotechnology Holdings, Inc. 680 E Colorado Blvd., Suite 180, Pasadena, CA 91101 United States of America Change Your